Renin released from mast cells activated by circulating MCP-1 initiates the microvascular phase of the systemic inflammation of alveolar hypoxia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 6, 2011, Pages 2264-2270

  Chao, Jie ^a   Blanco, Gustavo ^a   Wood, John G ^a,b   Gonzalez, Norberto C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme; Monocyte chemoattractant protein 1

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; CHEMICAL COMPOUND; DIPEPTIDYL CARBOXYPEPTIDASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RENIN; RENIN INHIBITOR; RS 102895; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; WESTERN BLOTTING;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANOXIA; BLOTTING, WESTERN; CELL DEGRANULATION; CELLS, CULTURED; CHEMOKINE CCL2; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; PEPTIDYL-DIPEPTIDASE A; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CCR2; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 82855167264     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00461.2011     Document Type: Article

References (32)

1. Andersson CK, Mori M, Bjermer L, Löfdahl CG, Erjefält JS. Novel site-specific mast cell subpopulations in the human lung. Thorax 64: 297-305, 2009.
2. Balcells E, Meng QC, Johnson WH Jr, Oparil S, Dell'Italia LJ. Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. Am J Physiol Heart Circ Physiol 273: H1769-H1774, 1997.
3. Caughey GH, Raymond WW, Wolters PJ. Angiotensin II generation by mast cell alpha- and beta-chymases. Biochim Biophys Acta 1480: 245-257 2000.
4. Chao J, Donham P, van Rooijen N, Wood JG, Gonzalez NC. MCP-1/CCL2 released from alveolar macrophages mediates the systemic inflammation of acute alveolar hypoxia. Am J Respir Cell Mol Biol 45: 53-61, 2011.
5. Chao J, Wood JG, Blanco VG, Gonzalez NC. The systemic inflammation of alveolar hypoxia is initiated by alveolar macrophage-borne mediator(s). Am J Respir Cell Mol Biol 41: 573-582, 2009.
6. Dix R, Orth T, Allen J, Wood JG, Gonzalez NC. Activation of mast cells by systemic hypoxia, but not by local hypoxia, mediates increased leukocyte-endothelial adherence in cremaster venules. J Appl Physiol 95: 2495-2502, 2003.
7. Doggrell SA, Wanstall JC. Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors. Can J Physiol Pharmacol 83: 123-130, 2005.
8. Gallwitz M, Enoksson M, Hellman L. Expression profile of novel members of the rat mast cell protease (rMCP)-2 and (RMCP)-8 families, and functional analyses of mouse mast cell protease (mMCP)-8. Immunogenetics 59: 391-405, 2007.
9. Gonzalez NC, Allen J, Blanco VG, Schmidt EJ, van Rooijen N, Wood JG. Alveolar macrophages are necessary for the systemic inflammation of acute alveolar hypoxia. J Appl Physiol 103: 1386-1394 2007.
10. Gonzalez NC, Allen J, Schmidt EJ, Casillan AJ, Orth T, Wood JG. Role of the renin-angiotensin system in the systemic microvascular inflammation of alveolar hypoxia. Am J Physiol Heart Circ Physiol 292: H2285-H2294, 2007.
11. Krop M, Özünal ZG, Chai W, de Vries R, Fekkes D, Bouhuizen AM, Garrelds IM, Danser AHJ. Mast cell degranulation mediates bronchoconstriction via serotonin and not via renin release. Eur J Pharmacol 640: 185-189, 2010.
12. Kunori Y, Muroga Y, Iidaka M, Mitsuhashi H, Kamimura T, Fukamizu A. Species differences in angiotensin II generation and degradation by mast cell chymases. J Recept Signal Transduct Res 25: 35-44, 2005.
13. McDonald J, Gonzalez NC, Wood JG. Mast cell degranulation promotes the cerebral microvascular inflammatory response to hypoxia (Abstract). FASEB J 17: A1282, 2003.
14. Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T, Silver RB, Levi R. Cardiac mast cell-derived renin promotes loa angiotensin formation, norepinephrine release and arrhythmias in ischemiareperfusion. J Clin Invest 116: 1063-1070, 2006.
15. Nakamura S, Averill DB, Chappell MC, Diz DI, Brosnihan KB, Ferrario CM. Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR. Am J Physiol Regul Integr Comp Physiol 284: R164-R173, 2003.
16. Orth T, Allen JA, Wood JG, Gonzalez NC. Plasma from conscious hypoxic rats stimulates leukocyte-endothelial interactions in normoxic cremaster venules. J Appl Physiol 99: 290-297, 2005.
17. Piqueras L, Kubes P, Alvarez A, O'Connor E, Issekutz AC, Esplugues JV, Sanz MJ. Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT1 and AT2 receptor mediated P-selectin upregulation. Circulation 102: 2118-2123, 2003.
18. Reilly CF, Tewksbury DA, Schechter Poole TJ, Zetter BR. Stimulation of peritoneal mast cell migration by tumor-derived peptides. Cancer Res 43: 5857-5861, 1983.
19. NM, Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophils and mast cell proteinases. J Biol Chem 257: 15, 8619-8622 1982.
20. Silver RB, Reid AC, Mackins CJ, Askwith T, Schaefer U, Herzlinger D, Levi R. Mast cells: a unique source of renin. Proc Natl Acad Sci USA 101: 13607-13612, 2004.
21. Shah S, Allen J, Wood JG, Gonzalez NC. Dissociation between skeletal muscle microvascular PO2 and hypoxia-induced microvascular inflammation. J Appl Physiol 94: 2323-2329, 2003.
22. Steiner DR, Gonzalez NC, Wood JG. Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J Appl Physiol 94: 325-334, 2003.
23. Takai S, Jin D, Muramatsu M, Okamoto Y, Miyazaki M. Therapeutic applications of chymase inhibitors in cardiovascular diseases and fibrosis. Eur J Pharmacol 501: 1-8, 2004.
24. Urata H, Nishimura H, Ganten D. Chymase-dependent angiotensin II forming systems in humans. Am J Hypertens 9: 277-284, 1996.
25. Veerappan A, Reid AC, Estephan R, O'Connor N, Thadani-Mulero M, Salazar-Rodirguez A, Levi R, Silver RB. Mast cell renin and a local angiotensin system in the airway: role in bronchoconstriction. Proc Natl Acad Sci USA 105: 1315-1320, 2008.
26. Wan MX, Wang Y, Liu Q, Schramm R, Thorlacius H. CC chemokines induce P-selectin-dependent neutrophil rolling and recruitment in vivo: intermediary role of mast cells. Br J Pharmacol 138: 698-706, 2003.
27. Wei CC, Hase N, Inoue Y, Bradley EW, Yahiro E, Li M, Navqi N, Powel PC, Shi K, Takahashi Y, Saku K, Urata H, Dell'Italia LJ, Husain A. Mast cell chymase limits the cardiac efficacy of Ang-I converting enzyme inhibitor therapy in rodents. J Clin Invest 120: 1229-1239, 2010.
28. Wintroub BU, Schechter NB, Lazarus GS, Kaempfer CE, Schwartz Angiotensin ILB. conversion by human, and rat chymotryptic proteinases. J Invest Dermatol 83: 336-339, 1984.
29. Wolny A, Clozel JP, Rein J, Mory P, Vogt P, Turino M, Kiowski W, Fischli W. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ Res 80: 219-227, 1997.
30. Wood JG, Johnson JS, Mattioli LF, Gonzalez NC. Systemic hypoxia promotes leukocyte-endothelial adherence via reactive oxidant generation. J Appl Physiol 87: 1734-1740, 1999.
31. Wood JG, Mattioli LF, Gonzalez NC. Hypoxia causes leukocyte adherence to mesenteric venules in nonacclimatized, but not in acclimatized rats. J Appl Physiol 87: 873-881, 1999.
32. Wood JG, Johnson JS, Mattioli LF, Gonzalez NC. Systemic hypoxia increases leukocyte emigration and vascular permeability in conscious rats. J Appl Physiol 89: 1561-1568, 2000.